Palatin Technologies, Inc. (PTN): Price and Financial Metrics


Palatin Technologies, Inc. (PTN)

Today's Latest Price: $0.45 USD

0.01 (1.70%)

Updated Nov 27 5:00pm

Add PTN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

PTN Stock Summary

  • Palatin Technologies Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 8.28% of US listed stocks.
  • The ratio of debt to operating expenses for Palatin Technologies Inc is higher than it is for about merely 8.37% of US stocks.
  • Revenue growth over the past 12 months for Palatin Technologies Inc comes in at -100.44%, a number that bests only 0.49% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Palatin Technologies Inc are NPTN, BCYC, HRTX, MYOV, and RMBS.
  • Visit PTN's SEC page to see the company's official filings. To visit the company's web site, go to www.palatin.com.

PTN Stock Price Chart Interactive Chart >

Price chart for PTN

PTN Price/Volume Stats

Current price $0.45 52-week high $0.83
Prev. close $0.44 52-week low $0.36
Day low $0.44 Volume 2,982,823
Day high $0.47 Avg. volume 1,726,030
50-day MA $0.43 Dividend yield N/A
200-day MA $0.49 Market Cap 103.43M

PTN Latest News Stream


Event/Time News Detail
Loading, please wait...

PTN Latest Social Stream


Loading social stream, please wait...

View Full PTN Social Stream

Latest PTN News From Around the Web

Below are the latest news stories about Palatin Technologies Inc that investors may wish to consider to help them evaluate PTN as an investment opportunity.

Palatin Technologies FQ4 results highlight $12M receipt from AMAG

Palatin Technologies ([[PTN]] -1.8%) reports FQ4 net loss of $7.3M.Termination of license agreement with AMAG Pharmaceuticals for Vyleesi in July 2020 resulted in receipt of $12M, and additional $4.3M due March 31, 2021.Phase 2 study data of PL9643 for the treatment of dry eye disease expected in calendar Q4 2020. "Our...

Seeking Alpha | September 28, 2020

Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q4 2020 Results - Earnings Call Transcript

Palatin Technologies, Inc. (PTN) Q4 2020 Results Conference Call September 28, 2020 11:00 AM ET Company Participants Carl Spana - President & CEO Steve Wills - EVP, CFO, & COO Conference Call Participants John Newman - Canaccord Joseph Pantginis - H.C. Wainwright & Co Edward Marks - Ladenburg Thalmann Presentation...

SA Transcripts on Seeking Alpha | September 28, 2020

Palatin Technologies Inc. (PTN) Q4 2020 Earnings Call Transcript

Palatin Technologies Inc (NYSEAMERICAN : PTN) Q4 2020 earnings call dated Sep. 28, 2020 Corporate Participants: Carl Spana — President and Chief Executive Officer Stephen T. Wills — Executive Vice President, Chief Financial Officer and Chief Operating Officer Analysts: John Newman — Canaccord Genuity — Analyst Joseph Pantginis — H.C. Wainwright & Co. — Analyst Michael Higgins — Ladenburg Thalmann — Analyst Presentation: Operator Good […]

AlphaStreet | September 28, 2020

5 Health Care Stocks Trading With Low Price-Earnings Ratios

Genesis tops the list Continue reading...

Yahoo | July 14, 2020

Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease

Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced reinitiation of enrollment of its Phase 2 study with PL9643 for the treatment of dry eye disease (DED).

Yahoo | July 8, 2020

Read More 'PTN' Stories Here

PTN Price Returns

1-mo 10.46%
3-mo -16.67%
6-mo -14.87%
1-year -45.45%
3-year -52.13%
5-year -35.71%
YTD -42.47%
2019 10.17%
2018 -17.35%
2017 68.43%
2016 -22.73%
2015 -9.59%

Continue Researching PTN

Want to see what other sources are saying about Palatin Technologies Inc's financials and stock price? Try the links below:

Palatin Technologies Inc (PTN) Stock Price | Nasdaq
Palatin Technologies Inc (PTN) Stock Quote, History and News - Yahoo Finance
Palatin Technologies Inc (PTN) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8433 seconds.